4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
9.66
+1.34 (16.11%)
At close: Oct 8, 2025, 4:00 PM EDT
9.74
+0.08 (0.83%)
After-hours: Oct 8, 2025, 7:47 PM EDT
4D Molecular Therapeutics Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$30.63
Upside
+217.08%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth Capital | Roth Capital | Strong Buy Maintains $44 → $38 | Strong Buy | Maintains | $44 → $38 | +293.37% | Aug 12, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +158.80% | Aug 12, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +158.80% | Aug 1, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +158.80% | Jul 3, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $28 → $25 | Strong Buy | Maintains | $28 → $25 | +158.80% | May 9, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $51 → $44 | Strong Buy | Maintains | $51 → $44 | +355.49% | May 9, 2025 |
| Barclays | Barclays | Buy Maintains $45 → $38 | Buy | Maintains | $45 → $38 | +293.37% | May 9, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $42 → $40 | Strong Buy | Maintains | $42 → $40 | +314.08% | Mar 10, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $30 → $28 | Strong Buy | Maintains | $30 → $28 | +189.86% | Mar 4, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $39 → $35 | Buy | Maintains | $39 → $35 | +262.32% | Mar 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +272.67% | Mar 3, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $39 → $30 | Strong Buy | Maintains | $39 → $30 | +210.56% | Feb 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +272.67% | Feb 10, 2025 |
| Morgan Stanley | Morgan Stanley | Sell Maintains $8 → $6 | Sell | Maintains | $8 → $6 | -37.89% | Jan 13, 2025 |
| Leerink Partners | Leerink Partners | Buy Maintains $31 → $27 | Buy | Maintains | $31 → $27 | +179.50% | Jan 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +272.67% | Jan 13, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.